| Q47254105 | A framework and case studies for evaluation of enzyme ontogeny in children's health risk evaluation |
| Q35001669 | Application of cryopreserved human hepatocytes in trichloroethylene risk assessment: relative disposition of chloral hydrate to trichloroacetate and trichloroethanol |
| Q35961038 | Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene |
| Q40895567 | Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. |
| Q47685054 | Covalent binding of trichloroethylene to proteins in human and rat hepatocytes |
| Q48148561 | Cytochrome P450 system as potential biomarkers of certain toxicants: comparison between plant and animal models |
| Q33916714 | Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment |
| Q34282835 | Differential response to trichloroethylene-induced hepatosteatosis in wild-type and PPARalpha-humanized mice |
| Q51534164 | Dose-dependent binding of trichloroethylene to hepatic DNA and protein at low doses in mice. |
| Q51582192 | Exploration of an interaction threshold for the joint toxicity of trichloroethylene and 1,1-dichloroethylene: utilization of a PBPK model. |
| Q48571911 | Extrahepatic metabolism by CYP2E1 in PBPK modeling of lipophilic volatile organic chemicals: impacts on metabolic parameter estimation and prediction of dose metrics |
| Q33916686 | Human variability and susceptibility to trichloroethylene |
| Q35985194 | Impact of environmental exposures on ovarian function and role of xenobiotic metabolism during ovotoxicity |
| Q84790027 | In vitro metabolism of [3H]2,6-dinitrotoluene by human and rat liver |
| Q38999765 | In vivo effects of naproxen, salicylic acid, and valproic acid on the pharmacokinetics of trichloroethylene and metabolites in rats |
| Q33916680 | Metabolism of trichloroethylene |
| Q35990446 | Modulation of hepatic and renal metabolism and toxicity of trichloroethylene and perchloroethylene by alterations in status of cytochrome P450 and glutathione. |
| Q36765703 | Ovarian metabolism of xenobiotics |
| Q40539163 | P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer |
| Q24820786 | PULMONARY BIOACTIVATION OF TRICHLOROETHYLENE TO CHLORAL HYDRATE: RELATIVE CONTRIBUTIONS OF CYP2E1, CYP2F, AND CYP2B1 |
| Q73414810 | Potential biomarkers of trichloroethylene and toluene exposure in Corbicula fluminea |
| Q41890329 | Regulatory heme and trichloroethylene intoxication: A possible explanation of the case of "A Civil Action". |
| Q33942236 | Renal toxicity and carcinogenicity of trichloroethylene: key results, mechanisms, and controversies |
| Q36139123 | The Contribution of Peroxisome Proliferator-Activated Receptor Alpha to the Relationship Between Toxicokinetics and Toxicodynamics of Trichloroethylene. |
| Q37835918 | The impact of CYP2E1 genetic variability on risk assessment of VOC mixtures |
| Q28305625 | Toluene metabolism by cDNA-expressed human hepatic cytochrome P450 |
| Q34626393 | Trichloroethylene biotransformation and its role in mutagenicity, carcinogenicity and target organ toxicity |
| Q51465847 | Trichloroethylene inhibits aldehyde dehydrogenase only for aliphatic aldehydes of short chains in rats. |
| Q37402279 | Trichloroethylene: Mechanistic, epidemiologic and other supporting evidence of carcinogenic hazard |
| Q23915083 | Use of kinetic and mechanistic data in species extrapolation of bioactivation: cytochrome P-450 dependent trichloroethylene metabolism at occupationally relevant concentrations |
| Q53490330 | [Health evaluation of trichloroethylene in indoor air : communication from the German ad-hoc working group on indoor guidelines of the Indoor Air Hygiene Committee and of the states' supreme health authorities]. |